News
Filter
-
Adding value to early stage IP
-
O2h provides multi-FTE -synthetic chemistry services to MRCT
-
MRCT’s call for targets
-
Collaboration between Georg-August-University Göttingen, Universitätsmedizin, the University of Regensburg and MRCT
-
DiscoveRX, GSK & MRCT collaborate to de-orphanise GPCRs
-
Bicycle Therapeutics is new MRC spinout
-
DiscoveRX GSK and MRCT collaborate to deorphanise GPCRs
-
Centre for Therapeutics Discovery
-
Heptares secures funding
-
UK Drug Discovery Consortium symposium
-
MRCT licence rights to develop potential novel immunotherapy
-
MRCT and Biolex Therapeutics complete successful collaborations
